BRD2 and obesity disorder: The distinction is made as women with NCCAH manifest greater concentrations of 17-hydroxyprogesterone and progesterone than women with PCOS, who present insulin resistance, obesity, polycystic ovary morphology, and increased LH/FSH ratios (28).